Trials / Unknown
UnknownNCT03129685
Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
Short-term Outcome of Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- The National Ribat University · Academic / Other
- Sex
- All
- Age
- 15 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of short-term outcomes of ipsilateral lobe arterial devascularization of the large hepatocellular carcinoma: single center non-randomized trial.
Detailed description
Assessment of the 30-day mortality and major complications as well as the tumor size changes of the patients undergoing ipsilateral lobe arterial devascularization of the large hepatocellular carcinoma. This is a prospective non randomized trial carried out at the Ribat University Hospital between April 2017 to March 2018.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | HALED | This is attained via a laparotomy involves isolation of the arterial blood supply of the tumor-containing liver lobe (the ipsilateral hepatic artery as well as the extrahepatic arterial collaterals) while preserving the feeding veins. |
Timeline
- Start date
- 2017-05-20
- Primary completion
- 2018-11-19
- Completion
- 2018-12-19
- First posted
- 2017-04-26
- Last updated
- 2018-06-12
Locations
1 site across 1 country: Sudan
Source: ClinicalTrials.gov record NCT03129685. Inclusion in this directory is not an endorsement.